Showing results (261-270 of 277) with videos related to

Sort By:
Pageof 28
Stroke|November 7, 2013
Stroke treatment academic industry roundtable: research priorities in the assessment of neurothrombectomy devicesJeffrey L Saver, Tudor G Jovin, Wade S Smith, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|September 10, 2015
A collaborative sequential meta-analysis of individual patient data from randomized trials of endovascular therapy and tPA vs. tPA alone for acute ischemic stroke: ThRombEctomy And tPA (TREAT) analysis: statistical analysis plan for a sequential meta-analysis performed within the VISTA-Endovascular collaborationRachael L MacIsaac, Pooja Khatri, Martin Bendszus, et al.
Stroke|January 28, 2022
Acute Ischemic Stroke, Depressed Left Ventricular Ejection Fraction, and Sinus Rhythm: Prevalence and Practice PatternsAnna D Baker, Lee H Schwamm, Danita Y Sanborn, et al.
BMC Neurology|January 17, 2019
Futile reperfusion and predicted therapeutic benefits after successful endovascular treatment according to initial stroke severitySang-Hwa Lee, Beom Joon Kim, Moon-Ku Han, et al.
Stroke|January 26, 2026
2026 Guideline for the Early Management of Patients With Acute Ischemic Stroke: A Guideline From the American Heart Association/American Stroke AssociationShyam Prabhakaran, Nestor R Gonzalez, Kori S Zachrison, et al.
JAMA|January 18, 2022
Effect of P2Y12 Inhibitors on Survival Free of Organ Support Among Non-Critically Ill Hospitalized Patients With COVID-19: A Randomized Clinical TrialJeffrey S Berger, Lucy Z Kornblith, Michelle N Gong, et al.
Stroke|October 22, 2015
Endovascular Therapy Is Effective and Safe for Patients With Severe Ischemic Stroke: Pooled Analysis of Interventional Management of Stroke III and Multicenter Randomized Clinical Trial of Endovascular Therapy for Acute Ischemic Stroke in the Netherlands DataJoseph P Broderick, Olvert A Berkhemer, Yuko Y Palesch, et al.
The Lancet. Diabetes & Endocrinology|September 9, 2024
Effect of sodium-glucose co-transporter-2 inhibitors on survival free of organ support in patients hospitalised for COVID-19 (ACTIV-4a): a pragmatic, multicentre, open-label, randomised, controlled, platform trialMikhail N Kosiborod, Sheryl L Windsor, Orly Vardeny, et al.
European Stroke Journal|January 7, 2020
Consensus statements and recommendations from the ESO-Karolinska Stroke Update Conference, Stockholm 11-13 November 2018Niaz Ahmed, Heinrich Audebert, Guillaume Turc, et al.
Lancet (London, England)|February 7, 2026
Recombinant factor VIIa versus placebo for spontaneous intracerebral haemorrhage within 2 h of symptom onset (FASTEST): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trialJoseph P Broderick, Andrew M Naidech, Jordan J Elm, et al.
Pageof 28